Dr. Victor Gurewich believes he has a better way to treat strokes and heart attacks. But no one wants to hear it.
The 88-year-old Harvard Medical School professor just wants to publicize and test what could be a groundbreaking treatment, but he has struggled to be taken seriously, Stat News detailed in a report published Friday. Gurewich's treatment combines two medications to quickly break clots and reduce potential brain damage until a patient can receive angioplasty, which pushes a clot away for good.
Gurewich ran a clinical trial on the treatment 23 years ago, but the company that ran it shut down. Instead of Gurewich's method, a drug called tPA rose to prominence.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
But tPA often causes seizures and brain bleeds, making some doctors afraid to use it. Gurewich thinks he could produce a safer alternative, and with his research, he should've be able to find funding for another clinical trial by now. But some professionals shoot down Gurewich's idea, saying it's out of date. Others have never even heard it.
But when Stat explained Gurewich's proposal to one medical professional, the doctor said it was a "nifty idea," and "maybe" even a "great" one. Gurewich has some other staunch supporters who "believe in the science" behind his work.
One foundation has kept Gurewich's company afloat for years, and it's finally helping his treatment take the next step: A clinical trial of 100 patients will start in the Netherlands this June. With more funding, the treatment should get a second trial in London. Read more about Gurewich's unending determination at Stat News.
-
Nepal chooses toddler as its new ‘living goddess’Under the Radar Girls between two and four are typically chosen to live inside the temple as the Kumari – until puberty strikes
-
October 5 editorial cartoonsCartoons Sunday's political cartoons include half-truth hucksters, Capitol lockdown, and more
-
Jaguar Land Rover’s cyber bailoutTalking Point Should the government do more to protect business from the ‘cyber shockwave’?
-
US tipped to help Kyiv strike Russian energy sitesSpeed Read Trump has approved providing Ukraine with intelligence for missile strikes on Russian energy infrastructure
-
Netanyahu agrees to Trump’s new Gaza peace planSpeed Read At President Trump's meeting with Israeli Prime Minister Benjamin Netanyahu, they agreed upon a plan to end Israel’s war in Gaza
-
Russia is ‘helping China’ prepare for an invasion of TaiwanIn the Spotlight Russia is reportedly allowing China access to military training
-
Moldova gives decisive win to pro-EU partySpeed Read The country is now on track to join the European Union within five years
-
Interpol arrests hundreds in Africa-wide sextortion crackdownIN THE SPOTLIGHT A series of stings disrupts major cybercrime operations as law enforcement estimates millions in losses from schemes designed to prey on lonely users
-
UK, 3 Western allies recognize Palestinian stateSpeed Read Britain, Canada, Australia and Portugal formally recognized the state of Palestine
-
Russia slams Kyiv, hits government buildingSpeed Read This was Moscow's largest aerial assault since launching its full-scale invasion in 2022
-
China's Xi hosts Modi, Putin, Kim in challenge to USSpeed Read Chinese President Xi Jinping hosted Indian Prime Minister Narendra Modi, Russian President Vladimir Putin and other Asian leaders at an SCO summit
